117 related articles for article (PubMed ID: 34932399)
1. Delta-tocotrienol enhances the anti-tumor effects of interferon alpha through reactive oxygen species and Erk/MAPK signaling pathways in hepatocellular carcinoma cells.
Lucci A; Vera MC; Comanzo CG; Lorenzetti F; Ferretti AC; Ceballos MP; Quiroga AD; Alvarez ML; Carrillo MC
Can J Physiol Pharmacol; 2022 May; 100(5):453-463. PubMed ID: 34932399
[TBL] [Abstract][Full Text] [Related]
2. A new xanthatin analogue 1β-hydroxyl-5α-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma.
Fang XY; Zhang H; Zhao L; Tan S; Ren QC; Wang L; Shen XF
Biochimie; 2018 Sep; 152():43-52. PubMed ID: 29960031
[TBL] [Abstract][Full Text] [Related]
3. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
Wang CJ; Xiao CW; You TG; Zheng YX; Gao W; Zhou ZQ; Chen J; Xue XB; Fan J; Zhang H
Mol Cancer; 2012 May; 11():31. PubMed ID: 22569271
[TBL] [Abstract][Full Text] [Related]
4. γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.
Rajendran P; Li F; Manu KA; Shanmugam MK; Loo SY; Kumar AP; Sethi G
Br J Pharmacol; 2011 May; 163(2):283-98. PubMed ID: 21198544
[TBL] [Abstract][Full Text] [Related]
5. Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model.
Siveen KS; Ahn KS; Ong TH; Shanmugam MK; Li F; Yap WN; Kumar AP; Fong CW; Tergaonkar V; Hui KM; Sethi G
Oncotarget; 2014 Apr; 5(7):1897-911. PubMed ID: 24722367
[TBL] [Abstract][Full Text] [Related]
6. δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis.
Fontana F; Marzagalli M; Raimondi M; Zuco V; Zaffaroni N; Limonta P
Cell Prolif; 2021 Nov; 54(11):e13111. PubMed ID: 34520051
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin.
Qureshi AA; Tan X; Reis JC; Badr MZ; Papasian CJ; Morrison DC; Qureshi N
Lipids Health Dis; 2011 Dec; 10():239. PubMed ID: 22185406
[TBL] [Abstract][Full Text] [Related]
8. EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells.
Wang C; Husain K; Zhang A; Centeno BA; Chen DT; Tong Z; Sebti SM; Malafa MP
J Nutr Biochem; 2015 Aug; 26(8):797-807. PubMed ID: 25997867
[TBL] [Abstract][Full Text] [Related]
9. Koumine Promotes ROS Production to Suppress Hepatocellular Carcinoma Cell Proliferation Via NF-κB and ERK/p38 MAPK Signaling.
Yuan Z; Liang Z; Yi J; Chen X; Li R; Wu J; Sun Z
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31581704
[TBL] [Abstract][Full Text] [Related]
10. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
11. δ-Tocotrienol induces apoptosis and inhibits proliferation of nasopharyngeal carcinoma cells.
Shen J; Yang T; Tang Y; Guo T; Guo T; Hu T; Luo F; Lin Q
Food Funct; 2021 Jul; 12(14):6374-6388. PubMed ID: 34056642
[TBL] [Abstract][Full Text] [Related]
12. Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells.
Shun MC; Yu W; Gapor A; Parsons R; Atkinson J; Sanders BG; Kline K
Nutr Cancer; 2004; 48(1):95-105. PubMed ID: 15203383
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation.
Ji X; Wang Z; Geamanu A; Sarkar FH; Gupta SV
J Cell Biochem; 2011 Oct; 112(10):2773-83. PubMed ID: 21598300
[TBL] [Abstract][Full Text] [Related]
14. Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.
Husain K; Centeno BA; Chen DT; Fulp WJ; Perez M; Zhang Lee G; Luetteke N; Hingorani SR; Sebti SM; Malafa MP
Carcinogenesis; 2013 Apr; 34(4):858-63. PubMed ID: 23302291
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial-dependent anticancer activity of δ-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells.
Viola V; Ciffolilli S; Legnaioli S; Piroddi M; Betti M; Mazzini F; Pierpaoli E; Provinciali M; Galli F
Biofactors; 2013; 39(4):485-93. PubMed ID: 23361894
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs.
Qureshi AA; Zuvanich EG; Khan DA; Mushtaq S; Silswal N; Qureshi N
Lipids Health Dis; 2018 Apr; 17(1):62. PubMed ID: 29606130
[TBL] [Abstract][Full Text] [Related]
17. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C
Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899
[TBL] [Abstract][Full Text] [Related]
18. γ-Tocotrienol induces apoptosis in human T cell lymphoma through activation of both intrinsic and extrinsic pathways.
Wilankar C; Khan NM; Checker R; Sharma D; Patwardhan R; Gota V; Sandur SK; Devasagayam TP
Curr Pharm Des; 2011; 17(21):2176-89. PubMed ID: 21774779
[TBL] [Abstract][Full Text] [Related]
19. Ca
Raimondi M; Fontana F; Marzagalli M; Audano M; Beretta G; Procacci P; Sartori P; Mitro N; Limonta P
Apoptosis; 2021 Jun; 26(5-6):277-292. PubMed ID: 33811561
[TBL] [Abstract][Full Text] [Related]
20. δ-Tocotrienol feeding modulates gene expression of EIF2, mTOR, protein ubiquitination through multiple-signaling pathways in chronic hepatitis C patients.
Qureshi AA; Khan DA; Mushtaq S; Ye SQ; Xiong M; Qureshi N
Lipids Health Dis; 2018 Jul; 17(1):167. PubMed ID: 30031388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
